Raymond James lowered the firm’s price target on Integer (ITGR) to $95 from $143 and keeps an Outperform rating on the shares after the stock tumbled 32% on news of headwinds from three customers limiting 2026 organic growth to LSD. The update came as a surprise to investors who were already skittish into the print, which actually saw reasonably solid Q3 results, the firm says. Sensitivity to customer confidentiality limits clarity, and Raymond thinks has further hindered the stock. While frustrating, the firm believes the breadth of exposures, as well as new launches to come in 2026 and beyond, enable that recovery beginning late 2026.
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ITGR:
Disclaimer & DisclosureReport an Issue
